GlassScriptPhysician profile
Julie Ann Rizzo
NPI 1255597258
$9,332.03
in general payments reported to CMS, 2019-2025
13 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2022: $381 · 2023: $480 · 2024: $7,881 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,649 · Food and Beverage: $1,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,648.61 |
| Food and Beverage | $1,937.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $8,274.77 | 2023-2025 | |
| Kerecis Limited | $380.67 | 2022 | |
| Medline Industries LP | $193.44 | 2023 | |
| Vericel Corporation | $125.00 | 2019 | |
| Polarityte, INC. | $121.91 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $118.74 | 2019 | |
| Pfizer INC. | $86.14 | 2025 | |
| Smith+Nephew, INC. | $31.36 | 2023 | Collagenase Santyl |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Rizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.